Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$26.24 - $39.63 $2.55 Million - $3.85 Million
-97,177 Reduced 41.96%
134,414 $5.29 Million
Q1 2023

May 15, 2023

BUY
$18.67 - $24.56 $672,120 - $884,160
36,000 Added 18.41%
231,591 $5.63 Million
Q4 2022

Feb 14, 2023

SELL
$17.24 - $23.95 $6.66 Million - $9.25 Million
-386,238 Reduced 66.38%
195,591 $4.19 Million
Q3 2022

Nov 14, 2022

SELL
$9.4 - $18.59 $3.58 Million - $7.08 Million
-380,641 Reduced 39.55%
581,829 $10.4 Million
Q2 2022

Aug 15, 2022

BUY
$9.12 - $18.9 $1.72 Million - $3.56 Million
188,340 Added 24.33%
962,470 $9.26 Million
Q1 2022

May 16, 2022

BUY
$12.15 - $16.83 $3.51 Million - $4.87 Million
289,129 Added 59.61%
774,130 $13 Million
Q3 2021

Nov 15, 2021

SELL
$7.07 - $17.5 $106,042 - $262,482
-14,999 Reduced 3.0%
485,001 $7.88 Million
Q2 2021

Aug 17, 2021

BUY
$5.69 - $7.17 $2.85 Million - $3.59 Million
500,000 New
500,000 $3.16 Million
Q3 2020

Nov 12, 2020

SELL
$4.01 - $6.29 $802,000 - $1.26 Million
-200,000 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$3.06 - $6.6 $234,322 - $505,401
76,576 Added 62.04%
200,000 $1.02 Million
Q1 2020

May 14, 2020

SELL
$2.83 - $8.44 $2.11 Million - $6.29 Million
-744,776 Reduced 85.78%
123,424 $425,000
Q4 2019

Feb 13, 2020

BUY
$0.93 - $8.58 $807,426 - $7.45 Million
868,200 New
868,200 $7.45 Million

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.